Publication Name	World Journal of Gastroenterology
Manuscript ID	81164
Country	China

Received	2022-10-28 01:06
Peer-Review Started	2022-10-28 01:07
To Make the First Decision
Return for Revision	2022-11-30 08:11
Revised	2022-12-12 18:10
Second Decision	2023-01-04 04:12
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-01-04 17:43
Articles in Press	2023-01-04 17:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-01-06 06:30
Publish the Manuscript Online	2023-01-12 10:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Chemistry, Medicinal
Manuscript Type	Letter to the Editor
Article Title	Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Jun-Hao Huang, Wei Guo and Zhe Liu
ORCID	Author(s) ORCID Number Jun-Hao Huang http://orcid.org/0000-0001-6501-599X Wei Guo http://orcid.org/0000-0003-0375-0950 Zhe Liu http://orcid.org/0000-0003-2950-3966
Funding Agency and Grant Number
Corresponding Author	Zhe Liu, MD, Doctor, Doctor, Professor, Surgeon, Department of Pancreatic-Biliary Surgery, The First Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang 110001, Liaoning Province, China. liuzhe4321@126.com
Key Words	Pancreatic cancer; Chemotherapy; Targeted therapy; Gemcitabine; Drug; Combination
Core Tip	In terms of the choice of chemotherapy regimen for pancreatic cancer, multi-drug chemotherapy is often applied in clinical practice. In general, the combination of chemotherapy and targeted therapy have better efficacy, but whether the combination of the two schemes is more effective than chemotherapy alone requires further investigations.
Publish Date	2023-01-12 10:19
Citation	Huang JH, Guo W, Liu Z. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World J Gastroenterol 2023; 29(3): 579-581
URL	https://www.wjgnet.com/1007-9327/full/v29/i3/579.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i3.579

Full Article (PDF)	WJG-29-579.pdf
Full Article (Word)	WJG-29-579.docx
Manuscript File	81164_Auto_Edited-LM.docx
Answering Reviewers	81164-Answering reviewers.pdf
Audio Core Tip	81164-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	81164-Conflict-of-interest statement.pdf
Copyright License Agreement	81164-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	81164-Language certificate.pdf
Peer-review Report	81164-Peer-review(s).pdf
Scientific Misconduct Check	81164-Bing-Wang JJ-2.png
Scientific Editor Work List	81164-Scientific editor work list.pdf
CrossCheck Report	81164-CrossCheck report.pdf